ACDM News Item

Recent update from the regulatory landscape in clinical data management

Date: September 24, 2026

On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.

You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections

Scroll down to the Pre-inspection documentation tab to find the:

GCP inspection dossier template – Computerised Systems
GCP inspection dossier clinical trial spreadsheet – Computerised Systems
GGP inspection dossier checklist – Computerised Systems.

MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.

An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.

For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:

Number of substantial protocol amendments/modifications
Number of change controls
How many of these change controls related to a protocol amendment/modification

The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.

Explore More News

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .

New MHRA Guidance

The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .